Esophageal Cancer: Epidemiology, Risk Factors and Diagnostic Methods

Author:

Gladilina I. A.1,Tryakin A. A.1,Zakhidova F. O.1,Malikhova O. A.1,Ivanov S. M.1,Kravets O. A.1,Shabanov M. A.1

Affiliation:

1. Federal State Budgetary Institution «N.N. Blokhin National Medical Research Center of Oncology» оf the Ministry of Health of the Russian Federation

Abstract

Introduction: Esophageal cancer (EC) is a malignant disease with low survival rates and limited treatment options in the later stages. The epidemiological situation in developed countries tends to improve. However, in most states, including the Russian Federation, the situation remains in critical condition.Epidemiology of EC: Esophageal cancer is one of the most aggressive malignant disease. According to the International Agency for Research on Cancer (IARC), in 2018, 572 thousand new cases of RP were registered in the world (3.2 % of the total number of malignant disease). In 2018, 508.6 thousand deaths from cancer were recorded in the world (5.3 % of the total number of deaths from cancer, 6th place) [1].EC risk factors: The following factors play an important role in the etiology of squamous EC:1. Diet (nitrites, hot food and drinks, insufficient intake of vitamins and minerals with food).2. Tobacco and alcohol use are independent risk factors, but when combined with others, they increasethe risk of the disease.3. Achalasia of the cardia.4. Burns of the esophagus.5. Autosomal dominant diseases characterized by hyperkeratosis of the palms of the hands and feet.The risk of developing EC reaches 37 % [2].6. Human papillomavirus types 16 and 18 causes a risk of EC in 37 % of patients.Diagnostic methods: Traditional methods for the diagnosis of EC are: esophagogastroduodenosocpy with biopsy, endoscopic ultrasound with puncture biopsy of the mediastinal lymph nodes, computed tomography of the chest and abdominal organs (including contrast), magnetic resonance imaging of the chest cavity (including with contrasting), positron emission tomography with 18F-fluorodeoxyglucose (including combined with computed tomography).

Publisher

Non-profit partnership Society of Interventional Oncoradiologists

Reference43 articles.

1. Bray F, Jacques Ferlay J, Soerjomataram I, et al. Global Cancer Statistics 2018. CA Cancer J Clin. 2018;68(Is.6):394-424.

2. Аллахвердиев АК, Давыдов МИ, Давыдов ММ и др. Клинические рекомендации. Рак пище- вода. [Allahverdiyev AK, Davydov MI, Davydov MM, et al. Clinical recommendations. Esophageal carcinoma] Moscow. 2018:5. (In Russ.)].

3. Каприн АД, Старинский ВВ, Петрова ГВ. Злокачественные новообразования в России в 2017 г. (заболеваемость и смертность). 2018:11-144. [Kaprin AD, Starinsky VV, Petrova GV. Malignant Neoplasms in Russia in 2017 (Morbidity and Mortality). 2018:11-144. (In Russ.)].

4. Мерабишвили ВМ. Выживаемость онкологических больных. Выпуск 2. Часть 1. Под ред. Ю.А. Щербука. 2011. С. 37. [Merabishvili VM. Survival of Cancer Patients. Issue 2. Part 1. P. 37 (In Russ.)].

5. Стилиди ИС. Рак пищевода. Энциклопедия клинической онкологии. Под ред. М.И. Давыдова. М. 2004. С. 26. [The style of IP. Esophageal Carcinoma. Encyclopedia of Clinical Oncology. Ed. by M.I. Davydov. Moscow. 2004:26 (In Russ.)].

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3